Leading the fight against cancer. Always focused on you.
We deliver personalized treatment you won't get anywhere else, led by a team of world-renowned doctors, specialists, and scientists.
Give today. Impact the care of tomorrow.
Your generosity helps support groundbreaking cancer research, world-class care for patients and their families, and vital education programs to train the next generation of cancer experts.
Changing how the world treats cancer through research
Our scientists pursue every aspect of cancer research — from exploring the fundamental biology of genes and cells, to developing immune-based treatments for cancer, uncovering the causes of metastasis, and more.
Let's get started
World-class experts. Close to you.
Many treatments and services are available at locations across NY and NJ.
Get care from the comfort of your home with telemedicine from MSK.
Explore MSK’s clinical trials
Our doctors and scientists work together so patients get access to cutting-edge treatments as soon as they are available.
ASCO 2023: MSK Experts to Present Leading Edge Research at the American Society of Clinical Oncology Annual Meeting
Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer during the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, June 2–6 in Chicago.Read more
What Are Cancer Vaccines? How Can They Prevent and Treat Cancer?
In this episode, Dr. Diane Reidy-Lagunes sits down with two physician-scientists at MSK researching vaccines and novel immunotherapies, Dr. Vinod Balachandran and Dr. Dmitriy Zamarin. They discuss the power of the body’s immune system to prevent and treat cancers, the difference between preventative and therapeutic vaccines, which cancers are treatable with vaccines, and the challenges that lie ahead.Listen now
MSK Announces $40M Gift To Establish The Marie-Josée Kravis Center for Cancer Immunobiology
The Marie-Josée Kravis Center for Cancer Immunobiology (CCI), made possible by a generous $40 million gift from Henry R. Kravis to honor the visionary leadership of his wife, Marie-Josée Kravis, will establish a strategic research infrastructure that will seamlessly unite MSK scientists and physicians to further accelerate immunotherapy treatments for people with cancer.Read more